Global Cord Blood (NYSE:CORBF) vs. Ontrak (NASDAQ:OTRK) Head to Head Analysis

Global Cord Blood (NYSE:CORBF) and Ontrak (NASDAQ:OTRK) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, valuation, profitability, dividends and institutional ownership.

Earnings and Valuation

This table compares Global Cord Blood and Ontrak’s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Global Cord Blood	$196.12 million	N/A	$79.04 million	N/A	N/A
Ontrak	$12.74 million	0.63	-$27.92 million	($6.17)	-0.05

Global Cord Blood has higher revenue and earnings than Ontrak.

Risk & Volatility

Global Cord Blood has a beta of -0.25, suggesting that its stock price is 125% less volatile than the S&P 500. Comparatively, Ontrak has a beta of 2.43, suggesting that its stock price is 143% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current ratings for Global Cord Blood and Ontrak, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Global Cord Blood	0	0	0	0	N/A
Ontrak	0	0	2	0	3.00

Ontrak has a consensus price target of $4.00, suggesting a potential upside of 1,265.19%. Given Ontrak’s higher possible upside, analysts clearly believe Ontrak is more favorable than Global Cord Blood.

Institutional and Insider Ownership

13.0% of Ontrak shares are held by institutional investors. 0.5% of Global Cord Blood shares are held by company insiders. Comparatively, 1.2% of Ontrak shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares Global Cord Blood and Ontrak’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Global Cord Blood	N/A	N/A	N/A
Ontrak	-219.10%	-657.19%	-126.99%

About Global Cord Blood

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2022, it operated three cord blood banks, including one in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as China Cord Blood Corporation and changed its name to Global Cord Blood Corporation in March 2018. Global Cord Blood Corporation is based in Central, Hong Kong. Global Cord Blood Corporation operates as a subsidiary of Blue Ocean Structure Investment Company Ltd.

About Ontrak

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. The company was incorporated in 2003 and is headquartered in Miami, Florida.